425 related articles for article (PubMed ID: 29486673)
21. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
22. Progress and pitfalls in the identification of cancer stem cell-targeting therapies in head and neck squamous cell carcinoma.
Kiang A; Yu MA; Ongkeko WM
Curr Med Chem; 2012; 19(35):6056-64. PubMed ID: 22963569
[TBL] [Abstract][Full Text] [Related]
23. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
24. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).
Jiang P; Xu C; Zhou M; Zhou H; Dong W; Wu X; Chen A; Feng Q
Carcinogenesis; 2018 Feb; 39(2):252-262. PubMed ID: 29228308
[TBL] [Abstract][Full Text] [Related]
25. Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells.
Ota I; Masui T; Kurihara M; Yook JI; Mikami S; Kimura T; Shimada K; Konishi N; Yane K; Yamanaka T; Kitahara T
Oncol Rep; 2016 Jan; 35(1):261-6. PubMed ID: 26498709
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
Najafi M; Mortezaee K; Ahadi R
Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
[TBL] [Abstract][Full Text] [Related]
27. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
28. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
29. The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment.
Zhang Y; Dong P; Yang L
Front Immunol; 2023; 14():1189323. PubMed ID: 37292204
[TBL] [Abstract][Full Text] [Related]
30. Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing.
Xiao M; Zhang X; Zhang D; Deng S; Zheng A; Du F; Shen J; Yue L; Yi T; Xiao Z; Zhao Y
Front Immunol; 2022; 13():1050951. PubMed ID: 36451812
[TBL] [Abstract][Full Text] [Related]
31. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
[TBL] [Abstract][Full Text] [Related]
32. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
[TBL] [Abstract][Full Text] [Related]
34. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells in head and neck squamous cell carcinoma: a review.
Satpute PS; Hazarey V; Ahmed R; Yadav L
Asian Pac J Cancer Prev; 2013; 14(10):5579-87. PubMed ID: 24289547
[TBL] [Abstract][Full Text] [Related]
36. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.
Bhat AA; Yousuf P; Wani NA; Rizwan A; Chauhan SS; Siddiqi MA; Bedognetti D; El-Rifai W; Frenneaux MP; Batra SK; Haris M; Macha MA
Signal Transduct Target Ther; 2021 Jan; 6(1):12. PubMed ID: 33436555
[TBL] [Abstract][Full Text] [Related]
37. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
38. Head and Neck Cancer Stem Cells: From Identification to Tumor Immune Network.
Dionne LK; Driver ER; Wang XJ
J Dent Res; 2015 Nov; 94(11):1524-31. PubMed ID: 26253189
[TBL] [Abstract][Full Text] [Related]
39. Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma.
Nieh S; Jao SW; Yang CY; Lin YS; Tseng YH; Liu CL; Lee TY; Liu TY; Chu YH; Chen SF
Head Neck; 2015 Dec; 37(12):1712-21. PubMed ID: 24986226
[TBL] [Abstract][Full Text] [Related]
40. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
